Study | Ethnicity | Examined year | Sample (n) | Age (years) | Definition of myopic maculopathy | Prevalence OR, 95% CI, % |
This current study | Chinese | 2013 | 3044 | ≥40 | Diffuse chorioretinal atrophy Patchy chorioretinal atrophy Macular atrophy Lacquer cracks CNV Fuchs’ spot | 5.8 (4.8 to 6.8); age-adjusted |
Hisayama Study13 | Southern Japanese | 2005 | 1892 | ≥40 | Diffuse chorioretinal atrophy Patchy chorioretinal atrophy Lacquer cracks Macular atrophy | 1.7 |
Beijing Eye Study15 | Urban Chinese | 2001 | 4319 | ≥40 | Staphyloma Lacquer cracks Fuchs’ spot Chorioretinal atrophy | 3.1 |
Shihpai Eye Study12 | Chinese | 2000 | 1058 | ≥65 | Lacquer cracks Deep choroidal atrophy Geographic atrophy CNV | 3.0 (2.1 to 4.2) |
Central India Eye and Medical Study16 | Rural Central India | 2006 | 4561 | >30 | Diffuse chorioretinal atrophy Patchy chorioretinal atrophy Macular atrophy Lacquer cracks CNV Fuchs’ spot Posterior staphyloma | 0.2 (0.1 to 0.4) |
Blue Mountains Eye Study8 | Urban Australian | 1992–1994 | 3583 | ≥49 | Staphyloma Lacquer cracks Fuchs’ spot Chorioretinal atrophy | 1.2 |
Yangxi Eye Study18 | Rural Southern Chinese | 2014 | 4469 | ≥40 | Diffuse chorioretinal atrophy Patchy chorioretinal atrophy Macular atrophy Lacquer cracks CNV Fuchs’ spot | 1.2 (1.1 to 1.2) |
Handan Eye Study17 | Rural Northern Chinese | 2006–2007 | 6603 | ≥30 | Staphyloma Lacquer cracks Fuchs’ spot Chorioretinal atrophy | 0.9 (0.7 to 1.1) |
CNV, choroidal neovascularisation.